The Business Times

Merck

Consumer & Healthcare

Merck to cut jobs and costs as demand for Gardasil in China remains weak

FILE PHOTO: Merck logo and decreasing stock graph are seen in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
Consumer & Healthcare

Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports

Merck submitted a nonbinding offer for MoonLake Immunotherapeutics earlier this year, according to the report, which added that the initial approach was rejected but talks could be revived.
Companies & Markets

Merck held talks to buy biotech MoonLake for over US$3 billion: FT

Merck can now integrate vaccine production within its own manufacturing network to supply global markets.
Consumer & Healthcare

China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million

Drugmakers have been racing to come up with pills that could duplicate the effects of Ozempic but would be more convenient to take.
Consumer & Healthcare

Merck snags Chinese obesity drug in nearly US$2 billion deal

Merck headquarters in Rahway, New Jersey, US, on Tuesday, April 18, 2023. Merck & Co. will buy Prometheus Biosciences Inc. for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. Photographer: Christopher Occhicone/Bloomberg
Consumer & Healthcare

Merck snags Chinese cancer drug for up to US$3.3 billion

Merck now expects total sales of up to US$64.1 billion for the year, US$300 million less than the top end of the guidance the company provided three months ago.
Consumer & Healthcare

Merck narrows sales outlook with Gardasil lagging in China

Merck narrowed expectations for its Life Science business, aiming for annual organic sales growth in a 7-to-9 per cent range from a previously anticipated 7 to 10 per cent.
Consumer & Healthcare

Germany’s Merck open to more M&A for its Life Science division

The deal is the latest in a string of recent acquisitions by Merck to reduce its reliance on blockbuster immunotherapy Keytruda, which is expected to face rivals by the end of the decade when it is set to lose patent protection.
Companies & Markets

Merck cuts annual profit forecast

"China is the largest end market for semiconductors with more than half of the world's total chip output going to China. Given the unprecedented capacity investment and expansion of domestic chip manufacturers, China is currently also the fastest growing semiconductor manufacturing market worldwide," Merck China president Allan Gabor said in a statement.
Technology

Germany's Merck to open semiconductor base in China

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More